Company / EPS (Basic)
Oruka Therapeutics, Inc. EPS (Basic) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$3.87
FY2024
5-year range
-$3.87 / -$0.69
FY2022-FY2024
Trend
-460.9%
vs FY2023
Sector context
#166 of 208
Health Care
What the data says
EPS (Basic) changed -461% YoY in FY2024, a notable deviation from the 2-year average annual change of -205%.
Based on SEC 10-K filings.
-3.87 in FY2024.
Declined from $-1.39 to $-3.87 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 208This company -$3.87 Sector average -$0.96
▼
-301.8% below sector average
Key checks
Key Insights
- In FY2024, eps (basic) decreased 460.9% year-over-year.
- Ranks #166 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.87 | -460.9% |
| FY2023 | -$0.69 | +50.4% |
| FY2022 | -$1.39 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026